{
    "organizations": [],
    "uuid": "32097b86a8dc0dfdc509a207f13d26badab67aa8",
    "author": "",
    "url": "https://www.reuters.com/article/brief-boehringer-ingelheim-and-lilly-ann/brief-boehringer-ingelheim-and-lilly-announce-an-academic-collaboration-with-university-of-oxford-idUSFWN1RT0AW",
    "ord_in_thread": 0,
    "title": "BRIEF-Boehringer Ingelheim And Lilly Announce An Academic Collaboration With University Of Oxford",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 16 PM / Updated 5 minutes ago BRIEF-Boehringer Ingelheim And Lilly Announce An Academic Collaboration With University Of Oxford Reuters Staff 1 Min Read \nApril 16 (Reuters) - Eli Lilly and Co: \n* BOEHRINGER INGELHEIM AND LILLY ANNOUNCE AN ACADEMIC COLLABORATION WITH UNIVERSITY OF OXFORD TO INVESTIGATE THE EFFECTS OF JARDIANCEÂ® IN ADULTS WITH CHRONIC KIDNEY DISEASE Source text for Eikon: Further company coverage:",
    "published": "2018-04-16T15:16:00.000+03:00",
    "crawled": "2018-04-16T15:30:57.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "ingelheim",
        "lilly",
        "announce",
        "academic",
        "collaboration",
        "university",
        "oxford",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "eli",
        "lilly",
        "co",
        "boehringer",
        "ingelheim",
        "lilly",
        "announce",
        "academic",
        "collaboration",
        "university",
        "oxford",
        "investigate",
        "effect",
        "adult",
        "chronic",
        "kidney",
        "disease",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}